Novel Plasma miRNAs as Biomarkers and Therapeutic Targets of Alzheimer’s Disease at the Prodromal Stage
Haining He(Sun Yat-sen University), Tao Wang(Tianjin University of Traditional Chinese Medicine), Huanqing Yang(Shanghai Jiao Tong University), Hua Xu(Institute of Basic Medical Sciences of the Chinese Academy of Medical Sciences), Zuoquan Xie(Chinese Academy of Sciences), Yan Feng(Seventh People's Hospital of Dalian), Ling Yue(Shanghai Mental Health Center), Bo Hong(Shanghai Jiao Tong University), Wei Zhang(Shanghai Jiao Tong University), Yuanyuan Liu(Sun Yat-sen University), Shifu Xiao(Shanghai Jiao Tong University), Minmin Zhang(Chinese Academy of Sciences), An Liu(Shanghai Jiao Tong University), Jinghua Wang(Shanghai Jiao Tong University)
Cited by 25
Related Papers
Long noncoding RNA GAS5 inhibits progression of colorectal cancer by interacting with and triggering YAP phosphorylation and degradation and is negatively regulated by the m6A reader YTHDF3
|Molecular Cancer|2019|647
Molecular determinants of cardiac fibroblast electrical function and therapeutic implications for atrial fibrillation
|Cardiovascular Research|2010|360
A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer’s dementia
|Alzheimer s Research & Therapy|2021|200
Evidence for Bidentate Substrate Binding as the Basis for the K48 Linkage Specificity of Otubain 1
|Journal of Molecular Biology|2009|146
Control of B Cell Development by the Histone H2A Deubiquitinase MYSM1
|Immunity|2011|131